Skip to content

Role of the sciatic nerve block in multimodal analgesia for aseptic foot and ankle surgery – Randomized controlled trial (RCT)

Role of the sciatic nerve block in multimodal analgesia for aseptic foot and ankle surgery – Randomized controlled trial (RCT) - IBFS

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036297
Enrollment
56
Registered
2025-04-01
Start date
2023-08-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain intensity and morphine consumption in aseptic foot and ankle surgery

Interventions

Group 1: Intervention group Blockade of the sciatic nerve with Local anesthetic (Ropivacain 0,375%) Group 2: Control group Sham block without local anesthetic

Sponsors

BG Unfallklinik Frannkfurt
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: - Elective bone surgery (osteosynthesis or osteotomies/repositions) on the foot or ankle under general anesthesia - Patients >= 18 years of age - Ability to give informed consent and willingness to participate in the study - Availability of a written declaration of consent - Sufficient knowledge of German

Exclusion criteria

Exclusion criteria: Exclusion criteria: - Patients < 18 years or incapable of giving consent - Emergency surgery - Pre-existing lesion of the lumbosacral plexus on the side to be operated on - Contraindications to the use of regional anesthesia (e.g. allergy to one of the drugs used, existing nerve lesions, etc.) - Particularly vulnerable persons: Children, adolescents, pregnant women and patients who are unable to give consent may not participate in the study. - Refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
Morphine equivalent consumption (MEQ consumption in milligrams) assuming equianalgesia (comparable pain scores) within the first 24 hours

Secondary

MeasureTime frame
Pain intensity on NRS from 0-10 at rest and during exercise/ movement every 6 hours within the first 24 hours, pain quality on NRS from 0-10, (bearable - unbearable)

Countries

Germany

Contacts

Public ContactThorsten Steinfeldt

BG Unfallklinik Frankfurt am Main

thorsten.steinfeldt@bgu-frankfurt.de+49694753064

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026